Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil

Fig. 3

Expression level of PPARG downstream target CK20 in colorectal cancer cell lines. Colorectal cancer cell lines HT29 and SW403 were treated with the PPARG agonists pioglitazone, rosiglitazone and siPPARG. After incubation for 48 hours, the protein expression level of the PPARG downstream target CK20 was measured using immunoblotting

Back to article page